Arlington Partners LLC

Position in GSK — GSK plc

CIK 1389848 BIRMINGHAM, AL

Position in GSK

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$282,438

+$40,596 QoQ

Shares Held

5,388

+23.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.45%

of 13F equity value

Holder Rank

#614

of 1,033 holders

Holding Since

Mar 2020

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Arlington Partners LLC holds $1,299,554 across 5 Drug Manufacturers - General names. GSK ranks #2 (21.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVO	Novo Nordisk A S	6,777	$324,889
2	GSK	GSK plc This page	5,388	$282,438
3	BMY	Bristol Myers Squibb Co	4,854	$279,687
4	NVS	Novartis AG	1,579	$247,460
5	JNJ	Johnson & Johnson	650	$165,080

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$282,438	5,388	+23.0%	Shares	Sole	2026-07-07
2026-03-31	$241,842	4,382	-96.5%	Shares	Sole	2026-04-09
2025-09-30	$5,427,283	125,748	+106.1%	Shares	Sole	2025-10-28
2025-06-30	$2,342,476	61,002	+18963.1%	Shares	Sole	2025-07-14
2023-06-30	$11,404	320	-38.5%	Shares	Sole	2023-07-26
2021-12-31	$22,491	520	+322.8%	Shares	Sole	2022-01-18
2020-03-31	$4,570	123	—	Shares	Sole	2020-04-13
No filing history on record for this holder in this stock.